51454 Efficacy and safety of apremilast in pediatric patients with moderate-to-severe plaque psoriasis: 52-week results from the SPROUT randomized controlled trial

Autor: Fiorillo, Loretta, Becker, Emily, Armesto, Susana, Paller, Amy S., Kontzias, Apostolos, Oberoi, Rajneet K., Klyachkin, Yuri, Amouzadeh, Hamid, Zhang, Zuoshun, Arkin, Lisa
Zdroj: In Journal of the American Academy of Dermatology September 2024 91(3) Supplement:AB35-AB35
Databáze: ScienceDirect